\
&
Contact us
\
&
Contact us
Published on | 5 years ago
ProgrammesCOVID-X, an exclusive acceleration program funded by the European Union to defeat COVID-19 clinical challenges through the power of data, has launched the Open Call #1 for European Tech Companies with outstanding Data Technology solutions that can overcome COVID-19 clinical challenges and save lives. This Open Call is also addressed for healthcare providers dealing with coronavirus patients and validating the solutions in real care environments.
Specifications:
All details and possibility to apply can be found by clicking here - deadline January 27h, 2021 at 17:00 (noon) CET
Three webinars will be organized about the application process and what you can expect from COVID-X programme:
When applying, please inform NCP advisor lieve.apers@vlaio.be.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
